Department of Radiosurgery, Medical Radiological Research Center of Russian Academy of Medical Sciences, Obninsk 249036, Russian Federation.
J Clin Endocrinol Metab. 2011 Feb;96(2):385-93. doi: 10.1210/jc.2010-1634. Epub 2010 Nov 17.
Papillary thyroid carcinoma (PTC) in patients exposed to environmental radioiodine after the Chernobyl accident is thought to have a relatively aggressive clinical course. Long-term results of treatment are not well known, especially in comparison with sporadic PTC.
The determination of risk factors for PTC recurrence in a controlled for baseline factors group of patients with radiation-related and sporadic PTC.
Retrospective cohort study involving patients treated for PTC and followed-up in 1991-2008. Risk factors were assessed by stratified analysis using the proportional hazard model.
Referral center-based.
A total of 497 patients were enrolled. Patients exposed to radioiodine were 172 individuals with reconstructed individual radiation thyroid doses ranging 51-3170 mGy. Patients with sporadic PTC included 325 individuals matched to exposed patients for sex, age ± 5 yr and time to treatment ± 2 yr.
Cancer recurrence.
Nodal disease increased the recurrence rate (HR = 5.21; 95% CI = 1.63-16.7) while the presence of tumor capsule (HR = 0.17; 95% CI = 0.06-0.45) and, particularly, treatment according to the Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer significantly reduced it (HR = 0.16; 95% CI = 0.06-0.42). None of the tested variables interacted with radiation factor.
PTC developing after internal exposure to radioiodine does not display specific risk factors for recurrence different from those in sporadic PTC. Common treatment approaches for patients with PTC should be recommended regardless of a history of radiation exposure.
切尔诺贝利事故后暴露于环境放射性碘的患者的甲状腺乳头状癌(PTC)被认为具有相对侵袭性的临床病程。长期治疗结果尚不清楚,特别是与散发性 PTC 相比。
在基线因素控制的基础上,确定放射性和散发性 PTC 相关患者的 PTC 复发的危险因素。
回顾性队列研究,纳入 1991-2008 年接受 PTC 治疗并随访的患者。使用比例风险模型进行分层分析评估危险因素。
基于转诊中心。
共纳入 497 例患者。接受放射性碘治疗的患者为 172 例,个体重建的甲状腺辐射剂量范围为 51-3170 mGy。散发性 PTC 患者包括 325 例与暴露患者匹配的个体,性别、年龄 ± 5 岁和治疗时间 ± 2 岁。
癌症复发。
淋巴结疾病增加了复发率(HR = 5.21;95%CI = 1.63-16.7),而肿瘤包膜的存在(HR = 0.17;95%CI = 0.06-0.45),特别是根据修订后的美国甲状腺协会甲状腺结节和分化型甲状腺癌管理指南进行治疗,显著降低了复发率(HR = 0.16;95%CI = 0.06-0.42)。测试的变量均未与辐射因素相互作用。
放射性碘内暴露后发生的 PTC 复发没有不同于散发性 PTC 的特定危险因素。无论是否有辐射暴露史,都应推荐用于 PTC 患者的常规治疗方法。